The trial enrolled patients with stage IV pancreatic cancer, where median life expectancy is just 6 to 12 months
The trial will enroll up to 42 patients in Finland across four cohorts
Neupharma gains exclusive rights to develop and commercialize corticorelin for peritumoral brain edema
The early-stage study will test the drug’s safety, tolerability and biological effects in humans
The conflict is also triggering a widening public health emergency
The protections extend through at least 2035, with the potential for further extensions
The initiative will focus on creating healthier early-life environments, promoting physical activity, identifying risks early, and strengthening preparedness within primary health care systems
The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth
The trial met its primary endpoint, with patients receiving povetacicept achieving a 52.0% reduction in UPCR at Week 36
The approval comes after a systematic review of published literature
Subscribe To Our Newsletter & Stay Updated
